Yard Driver Clinical Research
Resume:
Kenneth Alvarez Marquez
Duncan, SC 29334
Cell: 864-***-****
E-mail: *****************@*****.***
Education
**** – 1997 Medical Degree
Universidad Central del Este
San Pedro de Macoris
Dominican Republic
Internships
1997 Internal Medicine, Pediatrics, Obstetrics & Gynecology, Surgery Experience:
Redi-Group/ BMW Plant
3519 Pelham Rd, Greenville, SC 29615
December 18
th
, 2023 to Present
Yard Driver
Federal Express
135 Fed Ex Way
Greenville, SC 29605
2013- 2023
Switcher / Yard Driver
Florida Technical College
1199 S Woodland Blvd,
Deland, FL 32720
Professor Medical Programs
2011- 2012
Classes: Pharmacology; Cardiology; Anatomy and Physiology; Medical Terminology; Electrocardiogram; Phlebotomy; Medical & Clinical Procedures; Vital Signs; Professional Development; Introduction to Health Careers CPR, BLS & AED Angley College
1700 South Woodland Blvd
Deland, FL 32720
Director Medical Programs
2007-2008
Professor Medical Programs
2007-2011
Classes: Anatomy and Physiology; Pharmacology & Nutrition; Electrocardiogram; Medical Terminology; Professional Development; Medical & Clinical Procedures; Vital Signs; Phlebotomy; Introduction to Health Careers CPR, BLS & AED Medical Research Group of Central Florida
Sub-Investigator / Clinical Research Coordinator
2002-2006
2725 Rebecca Lane Suite 107
Orange City, FL 32763
1403 Medical Plaza Dr. Suite 202
Sanford, FL 32771
Princeton Biomedical Research, PA
Sub-Investigator / Clinical Research Assistant
1998-2001
Woodlands Professional Building
256 Bunn Drive, Suite 6
Princeton, NJ 08540
Princeton Biomedical Research, PA (West Caldwell Office) Sub-Investigator / Clinical Research Assistant
Durkin & Durkin Professional Building
1120 Bloomfield Ave,
West Caldwell, NJ 07070
Pfizer: A randomized, multicenter, double blind, double-dummy trial comparing Azythromycin 500mg daily for 3 days with Clarythromycin 1 gram daily for 10 days for the treatment of Acute Bacterial Exacerbation of Chronic Bronchitis.
Merck: A placebo-controlled, parallel group, 4 week trial conducted under double blind conditions to assess the efficacy and safety of Rofecoxib in patients with Chronic Low Back Pain. Glaxo Wellcome: A six week trial of Alosetron Hydrocloride 1 mg twice daily as empirical therapy in female subjects with symptoms of non-constipated Irritable Bowel Syndrome. Pharmacia & Upjohn: The effect of PNU-182716 on HbA1c levels in Type II Diabetic patients, a double-blind, placebo controlled, randomized, multi-center, dose-finding and dose-frequency study.
Kyowa: A six week, outpatient, double-blind, placebo-controlled, randomized, parallel group, multi-center study of the safety and efficacy of KW-6002 for the treatment of Major Depressive Disorder.
Novartis: A double-blind, randomized, parallel-group, active and placebo-controlled study to evaluate safety and efficacy of NKP608 in patients with Social Phobia. Eisai: A 24 week, multicenter, randomized, double blind, placebo-controlled evaluation of the efficacy and safety of Donepezil Hydrochloride (E2020) in patients with Dementia Associated with Cerebrovascular Disease.
Forest: Fixed dose comparison of the safety and efficacy of Lu 26-054, Citalopram, and placebo in the treatment of Major Depressive Disorder.
Parke-Davis: A double-blind, randomized, placebo-controlled study of Atorvastatin as prevention of Cerebrovascular Events in patients with a previous Transient Ischemic Attack TIA) or Stroke.
Organon: A multi-center, randomized, double- blind, Sertraline-controlled study of the efficacy and safety of Rameron (Mirtazapine) in subjects with Major Depressive Disorder who failed on SSRI (Selective Serotonin Re-uptake Inhibitor) treatment due to lack of efficacy. Cephalon: A 10 week, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Gabitril at 4, 8, and 12 mg/day in the treatment of adults with Generalized Anxiety Disorder.
Solvay: A randomized, double-blind, placebo-controlled, safety and tolerability study of Bifeprunox in the treatment of elderly patients with Psychotic symptoms ( S1543016 ). Pharmacia & Upjohn: Linezolid vs Cefadroxil in the treatment of skin and structure infections in children.
Boehringer Ingelheim: A double-blind, randomized, placebo-controlled, parallel group trial to determine the efficacy, safety and tolerability of [dose 1] [ dose 2 ] mg NS2330 given once per day for 26 weeks, in patients with mild to moderate Dementia of the Alzheimer’s type. Martek Biosciences: A randomized, double-blind, placebo-controlled study to evaluate the effects of DHA (eg; Docosahexaenoic acid) on cognitive functions in the elderly. Glaxo Wellcome: A multi-center, double-blind, placebo-controlled, randomized, fixed-dose evaluation of the safety and efficacy of Lamotrigine in the long term prevention of relapse and recurrence of Depression and / or Mania in patients with Bipolar I Disorder. Corcept Therapeutics: A randomized, double-blind, placebo-controlled, parallel group study of the safety and efficacy of three dose levels of CORLUX (mifepristone) plus an antidepressant vs placebo plus an antidepressant in the treatment of psychotic symptoms in patients with Major Depressive Disorder with Psychotic Features (PMD). Solvay: A multicenter, randomized, double-blind, parallel-group, placebo-controlled, efficacy, safety and tolerability study of Dronabinol MDI in the Acute treatment of Migraine Headache. Eisai: A 30 week, open label evaluation of Donepezil Hydrochloride (E2020) in patients with Dementia Associated with Cerebrovascular Disease (Vascular Dementia Extension Protocol). Forest: Placebo controlled evaluation of the safety and efficacy of Lu 26-054 in the prevention of Depression Relapse
Pharmacia & Upjohn: Pharmacogenomics blood sampling and analysis protocol for PNU- 182716, Diabetes Extension Protocol (Genetics).
Glaxo Wellcome: A double- blind, randomized, placebo-controlled, surveillance study of Asthma Event Outcomes in subjects receiving either usual pharmacotherapy of Asthma or usual pharmacotherapy plus Salmeterol 42 MCG (2 puffs) twice daily. References: Available upon Request
Contact this candidate